George Putnam
The Turnaround Letter
Geoffrey Seiler
Bullmarket.com
Chuck Carlson
The DRIP Investor
Nicholas Vardy
Bull Market Alert

Ebix (EBIX): A stock split buy


Bookmark and Share

 In his 2-for 1 advisory, Neil Macneale focuses exclusively on buying stocks that have just announced upcoming stock splits. The latest buy in his portfolio is Ebix (NASDAQ: EBIX).

"As the holidays and the year-end approach, I am feeling much more optimistic about the market and the  2 for 1 portfolio.

Advertisement
Banner

"Our latest buy is Ebix; the company has announced a 3 for 1 split on 10/12/09, to be delivered on 12/10/09. This is rather remarkable given this company split its shares 3 for 1 just one year ago.

"Ebix develops and sells software for the insurance industry. The company is based in Atlanta, GA but, in fact, is an international business. Fortune magazine ranked Ebix #4 on its August, 2009 list of the 100 fastest growing companies and #2 as the best investment within that group.

"So what’s to like? The company has a relatively high PE ratio, pays no dividend, and has a rather precarious balance sheet. This is not my type of stock and I was not interested when the split was first announced.

"However, there is the growth. Apparently, what Ebix sells has become essential within the insurance industry as companies strive to cut costs and to become more customer friendly. Ebix has had an average growth in earnings of over 66% per year for the last five years.

"And experts see no reason to think there is a slowdown over the horizon as the world’s economies and the insurance industry recover from the recession. Growth like this makes Ebix look very undervalued.

"While I’m a little out of my comfort zone with this recommendation, it seems worth the risk. As split stories go, Ebix has one of the best and, after all, our portfolio is all about stock splits."


News Flash

Goldcorp: 'My favorite major'
by Curtis Hesler, editor Professional Timing Service

The secular bull in gold and the commodity sector is not over. However, it is not at the ground floor any longer either; as such, stock selection must be more carefully considered.


Read more...

 

Money manager's small cap buys
by Jim Oberweis Jr., editor The Oberweis Report

Small-cap growth stock valuations are cheap, and like most things in life, economies are cyclical, even if this is a long and painful one. For the rare, brave contrarian with a reasonably long time horizon, that spells opportunity.


Read more...


   

Opportunities in homebuilding?
by Bernie Schaeffer, editor Schaeffer's Investment Research

Based on our "expectational analysis" strategy -- which  combines fundamental, sentiment and technical metrics -- I initiated long positions in two homebuilding stocks: Lennar Corporation (LEN) and Toll Brothers (TOL).


Read more...

 

Cliffs Natural: A DRIP favorite
by Vita Nelson, editor MoneyPaper

Our latest featured dividend reinvestment stock is Cliffs Natural Resources (CLF). Founded in 1847, the former Cleveland-Cliffs is the largest producer of iron ore pellets in North America.


Read more...

 

S&P's trio of info tech ETFS
by Dylan Cathers, S&P Capital IQ Equity Analyst, S&P The Outlook

Information technology is one of four sectors that S&P Capital IQ’s Sector Strategy Group currently recommends investors overweight in their portfolios.


Read more...

 

Crescent Point: Bakken bet
by Brian Hicks, editor Wealth Advisory

Master Limited Partnerships (MLPs) are unique investments that combine the tax benefits of a limited partnership (LP) with the liquidity of common stock.


Read more...

 

Natural gas: A bottom?
by Jason Cimpl, editor Daily Profit

Natural gas has collapsed for the past four years and has been on a gradual decline for almost a decade. Prices topped near $16 in 2005 and then declined to $2. So did natural gas just bottom?


Read more...

 

FBR Focus bests 99% of peers
by Walter Frank, editor MoneyLetter

Funds that invest in a relatively few stocks or sectors are less diversified than broadly invested funds and their volatility can be much higher. But the team at FBR Focus (FBRVX) seems to be getting it right.


Read more...

 

Celgene: Catalysts ahead
by John McCamant, editor Medical Technology Stock Letter

Celgene (CELG) recently kicked off the 2012 JP Morgan Healthcare conference by pre-announcing 4Q11 results and providing 2012 guidance.


Read more...

 

Water, water
by Richard Band, editor Profitable Investing

In the current environment, investors should focus any new stock purchases on companies with recession-resistant franchises and generous dividends -- such as water utilities.


Read more...